Who owns CENTURY THERAPEUTICS INC?
- Ticker: IPSC
- CUSIP Number: 15673t100
Tip: Access positions for across all investors
Analyze quarterly positions in Century Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Century Therapeutics stock
Who bought or sold CENTURY THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors | 5.4M | $14M | 100% | Jun 2024 |
|
| VR Adviser | 5.4M | $9.2M | 0% | Sep 2024 |
|
| Boxer Capital | 3.9M | $6.7M | -20% | Sep 2024 |
|
| Casdin Capital | 3.2M | $5.5M | -38% | Sep 2024 |
|
| BlackRock | 3.0M | $5.1M | 100% | Sep 2024 |
|
| BlackRock | 2.9M | $7.4M | 93% | Jun 2024 |
|
| Vanguard Group | 1.7M | $4.4M | 52% | Jun 2024 |
|
| DAFNA Capital Management | 1.7M | $2.9M | 0% | Sep 2024 |
|
| Syncona Portfolio | 1.0M | $2.6M | 100% | Jun 2024 |
|
| Geode Capital Management | 968k | $1.7M | 3% | Sep 2024 |
|
| Tang Capital Management | 900k | $1.5M | 0% | Sep 2024 |
|
| Baker Bros. Advisors | 798k | $1.4M | 0% | Sep 2024 |
|
| State Street Corporation | 780k | $2.0M | 61% | Jun 2024 |
|
| Octagon Capital Advisors | 667k | $1.1M | -50% | Sep 2024 |
|
| Renaissance Technologies | 488k | $835k | 195% | Sep 2024 |
|
| Charles Schwab Investment Management | 355k | $608k | -11% | Sep 2024 |
|
| Northern Trust | 353k | $603k | 91% | Sep 2024 |
|
| Morgan Stanley | 229k | $583k | 7% | Jun 2024 |
|
| Bridgeway Capital Management | 158k | $402k | 34% | Jun 2024 |
|
| Acadian Asset Management | 119k | $202k | 100% | Sep 2024 |
|
| Bank of New York Mellon | 106k | $181k | -29% | Sep 2024 |
|
| Nuveen Asset Management | 106k | $269k | 76% | Jun 2024 |
|
| Wealth Enhancement Advisory Services | 78k | $200k | 0% | Jun 2024 |
|
| Jpmorgan Chase & Co | 72k | $123k | 258% | Sep 2024 |
|
| Goldman Sachs Group | 71k | $181k | 80% | Jun 2024 |
|
| Barclays | 62k | $106k | 284% | Sep 2024 |
|
| Rhumbline Advisers | 50k | $85k | -5% | Sep 2024 |
|
| Citadel Advisors | 37k | $64k | -29% | Sep 2024 |
|
| Citigroup | 34k | $61k | 224% | Sep 2024 |
|
| Dimensional Fund Advisors | 33k | $57k | -56% | Sep 2024 |
|
| Bank of America Corporation | 32k | $54k | 7% | Sep 2024 |
|
| Parametrica Management | 28k | $48k | 0% | Sep 2024 |
|
| CornerCap Investment Counsel | 26k | $44k | -49% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 25k | $43k | 121% | Sep 2024 |
|
| Wells Fargo & Company | 22k | $38k | 10% | Sep 2024 |
|
| AQR Capital Management | 21k | $36k | 100% | Sep 2024 |
|
| Alliancebernstein | 20k | $51k | 73% | Jun 2024 |
|
| Deutsche Bank Aktiengesellschaft | 20k | $33k | 169% | Sep 2024 |
|
| Lynx1 Capital Management | 19k | $33k | 100% | Sep 2024 |
|
| Jane Street | 18k | $31k | -78% | Sep 2024 |
|
| Ing Investment Management | 17k | $30k | 0% | Sep 2024 |
|
| Tower Research Capital | 17k | $43k | 291% | Jun 2024 |
|
| SG Americas Securities | 16k | $27k | 100% | Sep 2024 |
|
| T. Rowe Price Associates | 15k | $26k | 0% | Sep 2024 |
|
| New York State Common Retirement Fund | 14k | $24k | 0% | Sep 2024 |
|
| Founders Financial Securities | 10k | $17k | 0% | Sep 2024 |
|
| Russell Investments | 5.8k | $15k | 105% | Jun 2024 |
|
| Royal Bank of Canada | 5.4k | $8.7k | 25% | Sep 2024 |
|
| California State Teachers Retirement System | 3.3k | $5.7k | 0% | Sep 2024 |
|
| Smartleaf Asset Management | 1.6k | $2.6k | 100% | Sep 2024 |
|
| Advisor Group Holdings | 1.1k | $1.9k | 100% | Sep 2024 |
|
| Summit Investment Advisors | 905.00 | $1.5k | 0% | Sep 2024 |
|
| Amalgamated Bank | 706.00 | $999.978400 | 0% | Sep 2024 |
|
| Mark Sheptoff Financial Planning | 500.00 | $855.000000 | 100% | Sep 2024 |
|
| Sterling Capital Management | 146.00 | $249.995800 | 100% | Sep 2024 |
|
| NISA Investment Advisors | 136.00 | $232.995200 | -81% | Sep 2024 |
|
| GAMMA Investing | 131.00 | $223.996900 | -26% | Sep 2024 |
|
| CWM | 99.00 | $0 | 281% | Sep 2024 |
|
| Capital Performance Advisors | 12.00 | $21.000000 | 100% | Sep 2024 |
|
Who sold out of Century Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 379k | $966k |
| Federated Investors | Jun 2024 | 276k | $704k |
| Jacobs Levy Equity Management | Jun 2024 | 11k | $27k |
| Qube Research & Technologies | Mar 2024 | 334.00 | $1.4k |
| Ohio Pers | Jun 2024 | 100.00 | $255.000000 |
| Simplex Trading | Jun 2024 | 68.00 | $0 |